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The major tyrosine kinase from platelets was purified as a 51 kDa active enzyme which was shown to be 
a degradation product of the protooncogene product p60 - c src. Immuno-depletion experiments using a mono- 
clonal antibody recognizing p60c-src failed to remove band 3 phosphorylating activity from red blood cell 
membranes. The erythrocyte tyrosine kinase was not at all immunoprecipitated by this antibody under con- 
ditions where the platelet enzyme was immunoprecipitated. 
(Platelet, Red blood cell) Tyrosine kinase ~60’” Band 3 Dlflerentiation 
1. INTRODUCTION 
Since tyrosine kinases were first reported as 
products of viral oncogenes [l-3], similar en- 
zymatic activities have been found in different 
types of cells and tissues not infected by viruses 
[ 1,4-231. Some of these tyrosine kinases have been 
shown to be associated with growth factor recep- 
tors [24-351. The fundamental problem concerning 
these cellular tyrosine kinases is that phosphoryla- 
tion at tyrosine of any endogenous ubstrate with 
a known physiological function has never been 
described. Several studies have dealt with tyrosine 
kinase activities of normal human hematopoietic 
cells [9,14-231, and our group has reported very 
high levels of phosphotyrosine in red blood cells 
and platelets [15]. In red blood cells the major 
substrate phosphorylated at tyrosine was found to 
be the membrane anion channel, band 3 [ 14,151. A 
preliminary study has shown that the tyrosine 
kinase responsible for this band 3 phosphorylation 
was active in vivo in intact red blood cells, not 
associated with the insulin receptor of these cells, 
able to bind phosphocellulose at pH 8.5 and eluted 
from a HPLC-filtration column with an apparent 
molecular mass of 33 kDa [36]. We found that the 
major platelet tyrosine kinase behaved similarly on 
phosphocellulose and showed the same apparent 
molecular mass by HPLC-filtration (not shown). 
We therefore asked whether the major tyrosine 
kinase in human platelets and red blood cells was 
the same enzyme or not. We briefly report here 
purification of the major platelet tyrosine kinase 
and its identification as the ~60’~“” protein. We 
also show that endogenous phosphorylation at 
tyrosine of the anion channel band 3 in red blood 
cell membranes is not due to p60c-s” activity. 
2. MATERIAL AND METHODS 
2.1. Purification of platelet tyrosine kinase 
Platelets were obtained from blood freshly 
drawn from healthy volunteers or from outdated 
platelet units of the ‘Centre National de Transfu- 
sion Sanguine’. After washing, they were solubi- 
lized in a 50 mM Tris-HCl buffer, pH 9, contain- 
ing 1 mM EDTA, 1 mM ,&mercaptoethanol, 10 
mM E-aminocaproic acid, 10% (v/v) glycerol, 1% 
(v/v) aprotinin, 1 mM phenylmethylsulfonyl 
fluoride (PMSF) and 10% (v/v) Nonidet P-40. In 
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some experiments, a ‘cocktail’ of antiproteolytic 
agents (20 mM benzamidine, 0.1 mM pepstatin, 
0.1 mM antipain, 0.1 mM chymostatin, and 0.01 
mM leupeptin) was added. Phosphocellulose bind- 
ing was performed in the same buffer but at pH 
8.5 and 0.1% (v/v) NP-40. NaCl(0.5 M) was add- 
ed for elution. The active phosphocellulose luate 
was subjected to a preparative flat-bed isoelectric 
focusing [37] using Ultrodex granulated gel and a 
2117 Multiphor apparatus (LKB). Then two high- 
pressure liquid chromatography (HPLC) steps 
were performed on active fractions: firstly, an ion- 
exchange step on a TSK-DEAE-SPW column 
(7.5 x 75 mm) in a 5 mM Tris-HCl buffer, pH 8, 
containing 1 mM EDTA, 1 mM ,&mercaptoeth- 
anol, 5% (v/v) glycerol, and 0.1% (v/v) NP-40; 
secondly, a filtration step on a TSK G 3000-SW 
column (7.5 x 600 mm) in a 20 mM Tris-HCl buf- 
fer, pH 7.5, containing 0.1 M NaCl, 10 mM MgClz 
and 0.05% (v/v) NP-40. Fractions were subjected 
to one- [38] or two-dimensional [39] SDS- 
polya,crylamide gel electrophoresis, followed by 
Coomassie or silver [40] staining and auto- 
radiography. Partial proteolysis was performed 
in tubes according to Cleveland et al. [41]. 
Phosphoamino acid analysis was performed as 
described [ 1,421. 
2.2. Tyrosine kinase activity assays 
During purification, tyrosine kinase activity was 
monitored by phosphorylation of poly(Glu-Tyr) 
(glutamic acid : tyrosine, 4 : 1, Sigma) [36,43]. 
Autophosphorylation of the purified tyrosine 
kinase was performed as described [36]. The effect 
of TLCK [44] and phosphorylation of casein, 
histones, angiotensin II [6], phosphatidylinositol 
(Ptd Ins) and phosphatidylinositol 4-monophos- 
phate (Ptd Ins-4-P) [45,46] were assayed as 
described. Platelet and red cell membrane tyrosine 
kinase activities were also assayed using band 3 as 
substrate. Briefly, the phosphocellulose-unbound 
fraction from red blood cell membranes (which has 
been shown to contain band 3 itself and not band 
3 tyrosine kinase [36]) was incubated 10 min at 
30°C in the presence of the tyrosine kinase 
preparation and of 2 mM MnC12, 30pM vanadate 
and 7-8 PM [y3’P]ATP (20-40 Ci/mmol, NEN). 
Band 3 phosphorylation was then investigated by 
Laemmli’s method of electrophoresis [38]. 
2.3. Immunoprecipitation experiments 
The purified autophosphorylated 51 kDa pro- 
tein was immunoprecipitated [47] by an antiserum 
raised against the peptide Lys-Arg-Leu-Ile-Glu- 
Asp-Asn-Glu-Tyr-Val-Ala-Arg-Gln-Gly [48-5 11 
coupled to anatoxin from tetanos virus (kind gift 
from S. Fischer) or by the antisera raised in two 
rabbits immunized with the 51 kDa band excised 
from polyacrylamide preparative gels and 
homogenized with Freund complete or incomplete 
adjuvant. Immunoprecipitation experiments on 
unlabeled whole platelet or ghost extracts were per- 
formed using the antiplatelet 51 kDa protein or a 
monoclonal antibody, GDl 1 (IgGI type), strongly 
reacting with p60““” in several species [52] (kind 
gift from S.J. Parsons). Autophosphorylation was 
then assayed by adding to the immune-complex 
pellet 10 mM MnC12, 25 mM Tris-HCl, pH 7.4, 
(final concentrations) and 10 @i [Y~~P]ATP 
(NEN, 3000 Ci/mmol). 
2.4. Immuno-depletion experiments 
Rabbit antimouse IgG antiserum was bound to 
protein A-Sepharose (Pharmacia) then incubated 
with either normal mouse IgGl or GDll an- 
tibodies [52]. Solubilized extracts (l’J70, v/v, 
NP-40) from red blood cell ghosts were prein- 
cubated (3 h at 4’C) with the immobilized immune 
or nonimmune IgGs. After removal of the resin, 
supernatants were endogenously phosphorylated 
[36] in the presence of 2 mM MnC12, 30 FM 
vanadate and 7-8 FM [Y~~P]ATP (20-40 Ci/mmol, 
NEN) and analyzed by Laemmli’s method of elec- 
trophoresis [38]. Phosphocellulose eluates from 
ghost or platelet extracts and platelet purified 
tyrosine kinase were also incubated under the same 
conditions with the immobilized IgGs and the ef- 
fect on poly(Glu-Tyr) and band 3 kinase activities 
were assayed. 
3. RESULTS AND DISCUSSION 
3.1. Purification of the platelet tyrosine kinase 
As the platelet tyrosine kinase was 50-lOO-times 
more active on an exogenous ubstrate, poly(Glu- 
Tyr) [43], than was the red blood cell tyrosine 
kinase (not shown), we undertook purification 
from platelets. This tyrosine kinase was purified 
after solubilization of whole platelets at high 
detergent concentration as described in section 2. 
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The different steps of the purification procedure 
were: phosphocellulose exchange at pH 8.5, 
preparative isoelectric focusing, HPLC DEAE ex- 
change and HPLC filtration (not shown). Starting 
from the solubilization supernatant, a final 
purification of 1004-fold and an activity yield of 
2.2% were obtained. Both are probably greatly 
underestimated ue to a large decrease of activity 
during the purification procedure. The final 
purified fraction was autophosphorylated in the 
presence of 7-8 pM [Y~~P]ATP, 2 mM MnC12 and 
30 ,uM vanadate, then analyzed by SDS- 
polyacrylamide gel electrophoresis (fig.lA, lanes a 
and b). Two bands were detected after Coomassie 
blue or silver staining: a major band of 51 kDa 
which was the only phosphorylated protein 
detected on the autoradiogram and a minor non- 
phosphorylated band of 44 kDa. Two-dimensional 
electrophoresis [39] showed a pHi of 6.4 for the 51 
Fig. 1. (A) SDS-polyacrylamide gel electrophoresis. 
Purified platelet tyrosine kinase was radiolabeled in the 
presence of [y3’P]ATP: (a) Coomassie staining, (b) 
autoradiogram. Platelet tyrosine kinase was im- 
munoprecipitated by normal rabbit serum (c,e) or an- 
tiplatelet 51 kDa band (d,f) from final purified tyrosine 
kinase fraction (c,d) or phosphocellulose eluate from 
platelet extract (e,f). Autophosphorylation was then 
assayed in the immune complex itself. Positions of Mr 
markers are indicated. (B) Phosphoamino acid analysis 
of the autophosphorylated purified tyrosine kinase from 
platelets. Positions of free phosphate (Pi), 
phosphoserine (set), phosphothreonine (thr) and 
phosphotyrosine (tyr) are indicated. 
kDa protein (not shown). The only phosphoamino 
acid present in the autophosphorylated purified 
fraction was phosphotyrosine (fig. 1B). Two rab- 
bits were immunized with the 51 kDa band excised 
from the acrylamide gel. The antisera obtained 
specifically immunoprecipitated the 51 kDa pro- 
tein which was able to autophosphorylate in the 
immunecomplex (fig.lA, lanes c-f) and was 
therefore throught to be the tyrosine kinase itself. 
Phosphorylation of the IgG heavy chain was not 
observed. 
3.2. Characterization of the platelet tyrosine 
kinase 
The autophosphorylated 51 kDa tyrosine kinase 
was also specifically immunoprecipiated by an an- 
tiserum raised against the tyrosine autophos- 
phorylation peptide of p60’” [48-511 (not shown). 
In addition to poly(Glu-Tyr) the purified platelet 
tyrosine kinase was able to phosphorylate casein, 
whole histones, histone 2B, erythrocyte band 3 and 
angiotensin II, exclusively at tyrosine, but was 
unable to phosphorylate either Ptd Ins or Ptd 
Ins-4-P (not shown) [53]. 2 mM TLCK induced a 
80% inhibition of the autophosphorylation of the 
51 kDa band (not shown) [44]. 
No cellular tyrosine kinase of 51 kDa has so far 
been clearly characterized, but it is well known that 
Fig.2. Partial proteolytic digestion of purified platelet 
tyrosine kinase. Final purified fraction was 
autophosphorylated in the presence of [T~~P]ATP. Pro- 
teolytic cleavage was then omitted (a) or performed in 
the presence of(b) 1, (c) 5, (d) lOpg/ml of Staphylococ- 
cus aweus V8 protease [41]. 
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p60Src tyrosine kinase is highly sensitive to pro- 
teolysis and is often recovered, after purification, 
as a 52-54 kDa active enzyme [54-571. The ques- 
tion, therefore, was whether the 51 kDa tyrosine 
kinase we purified from platelets was the pro- 
teolyzed p60c-src enzyme. Four results argue in 
favour of this possibility. First, limited V8 pro- 
tease digestion [41] of the purified 
autophosphorylated 51 kDa protein resulted in a 
pattern compatible with those reported previously 
for p60STC [56-591, with a major peptide of 26-28 
kDa phosphorylated at tyrosine (fig.2). Second, 
platelet extracts prepared from either freshly 
drawn blood, in the presence of a cocktail of an- 
tiproteolytic agents (see section 2.1), or outdated 
platelet units were immunoprecipitated with a 
strong monoclonal anti-p60src antibody, GD 11 
[52]. Assay of autophosphorylation in the immune 
complex showed a highly phosphorylated 60 kDa 
band in fresh platelets while a highly 
phosphorylated 51 kDa band was observed in the 
outdated platelets, which were those generally used 
for the purification procedure (fig.3). Third, the 
two rabbit antisera raised against the 51 kDa pro- 
tein were able to immunoprecipitate the active 60 
kDa tyrosine kinase from fresh platelet extracts 
although much less efficiently that GD 11 (not 
shown). Fourth, the platelet tyrosine kinase activi- 
ty assayed with poly(Glu-Tyr) or band 3 as 
substrate could be efficiently removed from a 
platelet phosphocellulose luate or purified frac- 
tion by the GD 11 antibodies (fig.4, lane c). These 
findings confirm the data of Golden et al. [60] who 
reported a high level of p60c-“rc in human platelets. 
3.3. Band 3 phosphorylation in red blood ceils 
Some common chromatographic properties sug- 
gested that the platelet and red blood cell tyrosine 
kinases could be the same enzyme. However im- 
munoprecipitation experiments using either an- 
tiplatelet 51 kDa band antiserum or GD 11 an- 
tibody, followed by autophosphorylation assay in 
the immune complex, failed to detect a radiolabel- 
ed 60 or 51 kDa protein in red blood cell solubiliz- 
ed membranes (not shown). This could be due to 
a very low amount of p60c-s’c protein in red blood 
cells [60]. To establish or rule out the possibility 
that p60c-src is responsible for band 3 phosphoryla- 
tion in red blood cell membranes, we examined 
whether the GD 11 anti-p60src antibody was able to 
Fig. 3. Immunoprecipitation by anti ~60”” antibody. 
Soluble extracts were prepared from fresh drawn 
platelets (cd) or outdated platelets (a,b) and im- 
munoprecipitation was performed using GD 11 anti- 
p60ErC monoclonal antibody (a,d) or normal mouse IgGl 
(c,d). Autophosphorylation was then assayed in the im- 
mune complex itself. Autophosphorylated purified 
tyrosine kinase (e). Positions of M, 60000 and 51000 are 
Fig.4. Phosphorylation of band 3 by the red blood cell 
enzyme in a soluble ghost extract (a) and by the platelet 
purified tyrosine kinase (b,c) (as described in section 2 
after immuno-depletion by anti-p60s” GD 11 antibody 
(b) or normal mouse IgGl (c). Positions of M, 93000 and 
indicated. 5 1000 are indicated. 
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abolish the band 3 phosphorylating activity in a 
red blood cell extract. Band 3 has already been 
shown to be a substrate for tyrosine kinase(s) from 
human B lymphocytes [17] and more recently for 
purified p60”” protein and EGF receptor [61]. The 
role of these kinases in the endogenous 
phosphorylation of erythrocyte band 3, never- 
theless, has never been proved. We confirm in this 
paper that platelet tyrosine kinase is also active in 
phosphorylating band 3 in vitro. However, in frac- 
tions partially purified by phosphocellulose 
chromatography, the ratio of band 3 kinase activi- 
ty over poly(Glu-Tyr) kinase activity was at least 
20-fold higher for the erythrocyte enzyme than for 
the platelet enzyme (not shown). Ghosts were 
prepared, solubilized and incubated with im- 
mobilized normal mouse IgGl or GD 11 an- 
tibodies. Band 3 phosphorylating activity was then 
assayed on supernatants. Preincubation of the ex- 
tracts with anti-p60src antibodies had no effect on 
band 3 phosphorylation (not shown). Immuno- 
depletion experiments were also performed on 
purified platelet tyrosine kinase and on 
phosphocellulose eluates from either platelets or 
red blood cell membranes. Poly(Glu-Tyr) and 
band 3 kinase activities were then assayed on 
supernatants. Strong inhibition was observed in 
the case of the platelet tyrosine kinase towards 
both substrates either in purified fraction (more 
than 80% inhibition after 3 h incubation with im- 
mune IgG over the control with normal IgG7 or in 
phosphocellulose luate (60-70% inhibition after 3 
h incubation) (fig.4). In contrast, no decrease at all 
of the poly(Glu-Tyr) or band 3 tyrosine kinase ac- 
tivities was observed in the case of red blood cells 
after incubation with the p60src antibodies (not 
shown). 
The results reported in this paper establish 
therefore that the major red blood cell tyrosine 
kinase is different from the major platelet tyrosine 
kinase and is not p60C-Src. While the anion channel 
band 3 is a good in vitro substrate for various 
tyrosine kinases and especially for ~60”” ([17,61]; 
present paper), the tyrosine kinase responsible for 
endogenous phosphorylation of band 3 in red 
blood cell membranes is not p60c-src. The definitive 
characterization of the major red blood cell 
tyrosine kinase would require the purification of 
this enzyme, which has been so far difficult to per- 
form due to its low activity on an exogenous 
LETTERS September 1986 
substrate such as poly(Glu-Tyr) as compared to the 
high activity of p60c-s’c towards this substrate in 
platelets. This could be due not only to a low 
amount of enzyme but also to a low level of activi- 
ty of the red blood cell band 3 kinase towards this 
substrate poly(Glu-Tyr). Indeed a very efficient 
phosphorylation of band 3 at tyrosine is observed 
in either membranes or intact red blood cells [36]. 
A close association between the enzyme and band 
3 in the red cell membranes, suggested by Moham- 
ed and Steck [62], could also account for the 
strong in vivo band 3 kinase activity [36]. 
In platelets as well as in erythrocytes, which 
represent terminal differentiation stages in 
hematopoietic development, the functional role of 
these tyrosine kinase activities remains to be 
elucidated. A relationship between tyrosine kinase 
activity and differentiation has been strongly sug- 
gested for ~60”’ [63], namely in neural tissues [64] 
and in a transformed rat cell line where the v-src 
oncogene product is able to stop proliferation and 
to induce differentiation [65]. 
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